The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways
Xinwei Cao,1 Yajun Li,1 Jianrong Shi,2 Huifang Tang1 1Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University, Hangzhou, 310058, People’s Republic of China; 2Department of Clinical Laboratory, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Re...
Saved in:
Main Authors: | Cao X (Author), Li Y (Author), Shi J (Author), Tang H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches
by: Ilma Shakeel, et al.
Published: (2023) -
Update on therapeutic management of idiopathic pulmonary fibrosis
by: Tzouvelekis A, et al.
Published: (2015) -
Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
by: Yu Fujita
Published: (2022) -
Therapeutic potential of polyphenols against aging- induced idiopathic pulmonary fibrosis (IPF) via Bioinformatics analysis
by: Ankit Tripathi, et al.
Published: (2024) -
Idiopathic Pulmonary Fibrosis
Published: (2022)